 <!-- ****************** Find the errors in the html start ****************** -->
    <!-- <div style="border: 1px solid #000001; padding: 2px, margin-bottom: 5px;"><b>WARNING: RISK OF SERIOUS HARM OR DEATH WITH INTRAVENOUS ADMINISTRATION; SUBLOCADE RISK EVALUATION AND MITIGATION STRATEGY</b><br><b>•  Serious harm or death could result if administered intravenously. SUBLOCADE forms a solid mass upon contact with body fluids and may cause occlusion, local tissue damage, and thrombo-embolic events, including life threatening pulmonary emobli, if administered intravenously.</b></div><br><b>IMPORTANT SAFETY INFORMATION</b><br><br>Prescription use of this product is limited under the Drug Addiction Treatment Act.<br><br><b>CONTRAINDICATIONS</b><br><br>SUBLOCADE should not be administered to patients who have been shown to be hypersensitive to buprenorphine or any component of the ATRIGEL<sup>®<sup> delivery system<br><br><b>Please click here to full <a href="https://www.sublocade.com/Content/pdf/prescribing-information.pdf" target="_blank>Prescribing Information</a>, including BOXED WARNING</b> -->

        <!-- inline styles missing ";" after 2px.-->
        <!-- use ul to list items for bullets -->
        <!-- some copy isn't inside any tags so I wrapped them with a div-->
        <!-- sup is missing "/" in closing tag of delivery system -->
        <!-- target is missing a " at the end -->
<!-- ****************** Find the errors in the html end ****************** -->

<!-- ****************************************************************************************** -->

    <!-- ****************** my version starts ****************** -->
    <div style="border: 1px solid #000001; padding: 2px; margin-bottom: 5px;"><b>WARNING: RISK OF SERIOUS HARM OR DEATH WITH INTRAVENOUS ADMINISTRATION; SUBLOCADE RISK EVALUATION AND MITIGATION STRATEGY</b><br><ul><li>Serious harm or death could result if administered intravenously. SUBLOCADE forms a solid mass upon contact with body fluids and may cause occlusion, local tissue damage, and thrombo-embolic events, including life threatening pulmonary emobli, if administered intravenously.</li></ul></div>
    <div><br><b>IMPORTANT SAFETY INFORMATION</b><br><br>
        Prescription use of this product is limited under the Drug Addiction Treatment Act.<br><br><b>CONTRAINDICATIONS</b><br><br>SUBLOCADE should not be administered to patients who have been shown to be hypersensitive to buprenorphine or any component of the ATRIGEL<sup>®</sup> delivery system<br><br><b>Please click here to full <a href="https://www.sublocade.com/Content/pdf/prescribing-information.pdf" target="_blank">Prescribing Information</a>, including BOXED WARNING</b>
    </div>
